Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 2Unknown 1Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Lung Neoplasms 3Small Cell Lung Carcinoma 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Vascular Neoplasms 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Tongue Neoplasms 1Tobacco Use Disorder 1Stomach Neoplasms 1Solid Tumor, Adult 1Prostatic Neoplasms 1Neoplasms 1Mouth Neoplasms 1MR-PET Imaging 1Hip Fractures 1Endometrial Neoplasms 1Colorectal Neoplasms 1Bone Cysts, Aneurysmal 1Bone Cysts 1

Interventions

Oxaliplatin 81S 1 (combination) 55Capecitabine 44apatinib 32Paclitaxel 32Docetaxel 32Irinotecan 27Fluorouracil 22Drug Therapy 21sintilimab 20Cisplatin 20Leucovorin 16Hyperthermic Intraperitoneal Chemotherapy 13XELOX 12Surgical Procedures, Operative 12camrelizumab 10Trastuzumab 10titanium silicide 9Tegafur 9Nivolumab 9Neoadjuvant Therapy 9pembrolizumab 8Laparoscopy 8Gastrectomy 8Folfox protocol 7Chemotherapy, Adjuvant 7toripalimab 6tislelizumab 6Ramucirumab 6Gastroscopy 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Stomach Neoplasms × X-Rays × Clear all
NCT04535401 2024-10-10

Testing the Addition of an Anticancer Drug, BAY 1895344, to the Usual Chemotherapy With FOLFIRI in Advanced or Metastatic Cancers of the Stomach and Intestines

National Cancer Institute (NCI)

Phase 1 Unknown
10 enrolled
Gastrointestinal

Stomach Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡